Apple to roll out hypertension detection on smart watch after FDA nod
Feature will be available on Apple Watch Series 9, Series 10, Series 11, and Ultra 2 and Ultra 3 smartwatches
Apple is set to unveil the latest hypertension detection feature in its smartwatch by next week, after Food and Drug Administration (FDA) clearance on Thursday, Bloomberg News reported.
Apple and the FDA did not immediately respond to Reuters' requests for comment.
The company unveiled a blood pressure monitor in its latest Apple Watch at the September 9 event, where it also introduced a refreshed iPhone lineup, including a slimmer iPhone Air.
The feature, pending regulatory approval, will not detect every case of high blood pressure, but could alert about a million people, Apple said.
Available in 150 countries, the tool will use data from the watch's optical heart sensor to track how a user's blood vessels respond to heartbeats over 30 days, the report said, citing Apple.
The feature will be available on the Apple Watch Series 9, Series 10, Series 11, and its more expensive Ultra 2 and Ultra 3 smartwatches, Bloomberg News said.
-
‘Smiling electrons’ discovered in Earth’s magnetosphere in rare space breakthrough -
Archaeologists unearthed possible fragments of Hannibal’s war elephant in Spain -
NASA's Hubble Space Telescope discovers ‘Dracula Disk', 40 times bigger than solar system -
Annular solar eclipse 2026: Where and how to watch ‘ring of fire’ -
Scientists discover rare form of 'magnets' that might surprise you -
Humans may have 33 senses, not 5: New study challenges long-held science -
Northern Lights: Calm conditions persist amid low space weather activity -
SpaceX pivots from Mars plans to prioritize 2027 Moon landing